Andrew E. Mulberg

2.7k total citations
74 papers, 1.7k citations indexed

About

Andrew E. Mulberg is a scholar working on Surgery, Pediatrics, Perinatology and Child Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Andrew E. Mulberg has authored 74 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Surgery, 19 papers in Pediatrics, Perinatology and Child Health and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Andrew E. Mulberg's work include Pharmaceutical studies and practices (18 papers), Cystic Fibrosis Research Advances (14 papers) and Pediatric Hepatobiliary Diseases and Treatments (12 papers). Andrew E. Mulberg is often cited by papers focused on Pharmaceutical studies and practices (18 papers), Cystic Fibrosis Research Advances (14 papers) and Pediatric Hepatobiliary Diseases and Treatments (12 papers). Andrew E. Mulberg collaborates with scholars based in United States, Canada and Japan. Andrew E. Mulberg's co-authors include Richard J. Grand, Robert K. Montgomery, Douglas M. Jefferson, Steven M. Altschuler, Linda C. Rogers, Gilbert J. Burckart, Shelley A. Grubman, Barry Tulk, Michael Forgac and Richard F. Ittenbach and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Gastroenterology.

In The Last Decade

Andrew E. Mulberg

74 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew E. Mulberg United States	25	417	364	357	299	236	74	1.7k
Leena Patel United Kingdom	27	295 0.7×	467 1.3×	260 0.7×	325 1.1×	237 1.0×	117	2.3k
A. Jyothy India	26	255 0.6×	569 1.6×	140 0.4×	223 0.7×	263 1.1×	135	2.2k
Andrew P. Feranchak United States	33	608 1.5×	929 2.6×	964 2.7×	222 0.7×	314 1.3×	53	2.8k
Charles Buchanan United Kingdom	19	276 0.7×	417 1.1×	113 0.3×	267 0.9×	135 0.6×	53	1.5k
Zhuo Liu China	23	315 0.8×	455 1.3×	523 1.5×	99 0.3×	97 0.4×	134	1.7k
Tanja Gonska Canada	30	428 1.0×	485 1.3×	2.1k 5.9×	208 0.7×	140 0.6×	93	3.0k
Wael Salameh United States	24	322 0.8×	607 1.7×	117 0.3×	428 1.4×	186 0.8×	39	2.5k
Felice Amato Italy	23	159 0.4×	571 1.6×	458 1.3×	142 0.5×	71 0.3×	61	1.6k
Aiping Zhang China	24	260 0.6×	503 1.4×	117 0.3×	109 0.4×	139 0.6×	101	1.8k
Osamu Sakamoto Japan	25	325 0.8×	815 2.2×	221 0.6×	217 0.7×	363 1.5×	109	2.2k

Countries citing papers authored by Andrew E. Mulberg

Since Specialization

Citations

This map shows the geographic impact of Andrew E. Mulberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew E. Mulberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew E. Mulberg more than expected).

Fields of papers citing papers by Andrew E. Mulberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew E. Mulberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew E. Mulberg. The network helps show where Andrew E. Mulberg may publish in the future.

Co-authorship network of co-authors of Andrew E. Mulberg

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew E. Mulberg. A scholar is included among the top collaborators of Andrew E. Mulberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew E. Mulberg. Andrew E. Mulberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Denton, Nathan, et al.. (2021). Data silos are undermining drug development and failing rare disease patients. Orphanet Journal of Rare Diseases. 16(1). 161–161. 20 indexed citations

Kishnani, Priya S., et al.. (2020). Use of the patient-reported outcomes measurement information system (PROMIS®) to assess late-onset Pompe disease severity. Journal of Patient-Reported Outcomes. 4(1). 83–83. 7 indexed citations

Mulberg, Andrew E., et al.. (2019). Global Harmonization of Pediatric Drug Development: Critical for Progress for Developing Safe and Effective Therapeutic Agents for Children. Current Therapeutic Research. 90. 109–112. 4 indexed citations

Reinisch, Walter, Klaus Gottlieb, Jean‐Frédéric Colombel, et al.. (2018). Comparison of the EMA and FDA Guidelines on Ulcerative Colitis Drug Development. Clinical Gastroenterology and Hepatology. 17(9). 1673–1679.e1. 25 indexed citations

Schiffmann, Raphael, Daniel G. Bichet, Ana Jovanović, et al.. (2018). Migalastat improves diarrhea in patients with Fabry disease: clinical-biomarker correlations from the phase 3 FACETS trial. Orphanet Journal of Rare Diseases. 13(1). 68–68. 25 indexed citations

Shapiro, Elsa, Heather Adams, Ann Barbier, et al.. (2016). Neurocognitive clinical outcome assessments for inborn errors of metabolism and other rare conditions. Molecular Genetics and Metabolism. 118(2). 65–69. 26 indexed citations

Leffler, Daniel A., Sonia S. Kupfer, Benjamin Lebwohl, et al.. (2016). Development of Celiac Disease Therapeutics: Report of the Third Gastroenterology Regulatory Endpoints and Advancement of Therapeutics Workshop. Gastroenterology. 151(3). 407–411. 20 indexed citations

Gura, Kathleen M., Andrew E. Mulberg, Paul D. Mitchell, et al.. (2016). Pediatric Intestinal Failure–Associated Liver Disease: Challenges in Identifying Clinically Relevant Biomarkers. Journal of Parenteral and Enteral Nutrition. 42(2). 455–462. 10 indexed citations

Bai, Jane P. F., Gilbert J. Burckart, & Andrew E. Mulberg. (2015). Literature Review of Gastrointestinal Physiology in the Elderly, in Pediatric Patients, and in Patients with Gastrointestinal Diseases. Journal of Pharmaceutical Sciences. 105(2). 476–483. 47 indexed citations

10.

Turner‐Bowker, Diane M., et al.. (2015). Practical Considerations for the Use of Clinical Outcome Assessments (COAs) in Pediatric Clinical Research: Examples From Pediatric Gastroenterology. Therapeutic Innovation & Regulatory Science. 50(1). 37–43. 6 indexed citations

11.

Mulberg, Andrew E., et al.. (2014). Dependence of PERT Endpoint on Endogenous Lipase Activity. Pancreas. 43(8). 1232–1238. 2 indexed citations

12.

Trapnell, Bruce C., Steven Strausbaugh, Marlyn S. Woo, et al.. (2011). Efficacy and safety of PANCREAZE® for treatment of exocrine pancreatic insufficiency due to cystic fibrosis. Journal of Cystic Fibrosis. 10(5). 350–356. 26 indexed citations

13.

Rovner, Alisha J., Virginia A. Stallings, David A. Piccoli, Andrew E. Mulberg, & Babette S. Zemel. (2006). Resting energy expenditure is not increased in prepubertal children with Alagille syndrome. The Journal of Pediatrics. 148(5). 680–682. 3 indexed citations

14.

Olsen, Irene E., Richard F. Ittenbach, Alisha J. Rovner, et al.. (2004). Deficits in Size-Adjusted Bone Mass in Children with Alagille Syndrome. Journal of Pediatric Gastroenterology and Nutrition. 40(1). 76–82. 30 indexed citations

15.

Lowe, Mark E., et al.. (2002). Research Agenda for Pediatric Gastroenterology, Hepatology and Nutrition: Cystic Fibrosis and Pancreatic Diseases: Report of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition for the Children's Digestive Health and Nutrition Foundation. Journal of Pediatric Gastroenterology and Nutrition. 35. S258–S262. 2 indexed citations

16.

Rovner, Alisha J., Joan I. Schall, Abbas F. Jawad, et al.. (2002). Rethinking Growth Failure in Alagille Syndrome: The Role of Dietary Intake and Steatorrhea. Journal of Pediatric Gastroenterology and Nutrition. 35(4). 495–502. 21 indexed citations

17.

Montgomery, Robert K., Andrew E. Mulberg, & Richard J. Grand. (1999). Development of the human gastrointestinal tract: Twenty years of progress. Gastroenterology. 116(3). 702–731. 214 indexed citations

18.

Wei, Xiaofang, R Eisman, Andrew E. Mulberg, et al.. (1996). Turnover of the cystic fibrosis transmembrane conductance regulator (CFTR): Slow degradation of wild-type and ΔF508 CFTR in surface membrane preparations of immortalized airway epithelial cells. Journal of Cellular Physiology. 168(2). 373–384. 28 indexed citations

19.

Mulberg, Andrew E., et al.. (1995). Expression and localization of the cystic fibrosis transmembrane conductance regulator mRNA and its protein in rat brain.. Journal of Clinical Investigation. 96(1). 646–652. 53 indexed citations

20.

Mulberg, Andrew E., et al.. (1993). Identification of nonsteroidal antiinflammatory drug-induced gastroduodenal injury in children with juvenile rheumatoid arthritis. The Journal of Pediatrics. 122(4). 647–649. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact